Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 321-330 of 410 for multiple

Edit search filters
  1. A Study of XmAb ®18087 in Subjects With NET and GIST

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. Fecal Microbiome with Multiple System Atrophy

    Rochester, MN

  3. A Study to Assess the Effectiveness, Safety, Tolerability, and Drug/Body Interactions of ABBV-8E12 in Progressive Supranuclear Palsy

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. A Study of the Brain & Body Donation Program

  5. Multiple Imaging Evaluations of the Liver, Pancreas, and Fat

    Rochester, MN

  6. A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TRK-250 for Patients With Idiopathic Pulmonary Fibrosis

    Jacksonville, FL

  7. A Phase 1/2 Study of MRTX0902 in Solid Tumors With Mutations in the KRAS MAPK Pathway

    Rochester, MN

  8. Phase 1/2 Dose Escalation Study in Patients With Relapsed or Refractory Waldenstrom's Macroglobulinemia

    Rochester, MN, Jacksonville, FL

  9. Evaluation of Safety, Tolerability, and Effectiveness of INZ-701 in Adults With ENPP1 Deficiency

    Rochester, MN

  10. A First in Man Trial for Patients With Cancer

    Rochester, MN

.

Mayo Clinic Footer